Previous 10 | Next 10 |
2024-01-03 12:20:37 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Sidus Space Inc (NASDAQ: SIDU), ABVC Biopharma Inc (NASDAQ: ABVC), Dyne Therapeutics Inc (NASDAQ: DYN),...
2024-01-03 10:06:54 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ABVC Biopharma Inc (NASDAQ: ABVC), Dyne Therapeutics Inc (NASDAQ: DYN), Sidus Space Inc (NASDAQ: SIDU), Neximm...
2024-01-03 09:06:41 ET Companies mentioned; Neximmune Inc (NASDAQ: NEXI), Sigma Labs Inc (NASDAQ: SASI), First Wave BioPharma (NASDAQ: FWBI), Ucommune International Ltd (NASDAQ: UK), Siyata Mobile (NASDAQ: SYTA), and ABVC Biopharma Inc (NASDAQ: ABVC). DENVER, Colo., Jan. 3, 2024 ( www...
2024-01-03 08:13:35 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- ABVC BioPharma, Inc. (NASDAQ: ABVC) and its subsidiary, BioLite, Inc., stated, this morning, that they received an aggregate of 46 million shares from AiBtl BioPharma Inc. (“AiBtl”), as its first...
2024-01-03 08:08:56 ET More on ABVC BioPharma ABVC shares jump after signing licensing deal for CNS drugs Financial information for ABVC BioPharma For further details see: ABVC Biopharma and unit receive $460M as first milestone payment; shares jump
FREMONT, CA , Jan. 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) and its subsidiary BioLite, Inc. ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), ...
FREMONT, CA - ( NewMediaWire ) - December 07, 2023 - ABVC BioPharma, Inc . (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced an update on the Company's eight-week long AD...
FREMONT, CA , Dec. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (“ABVC” or the “Company”) (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and op...
2023-11-22 09:57:58 ET DENVER, Colo., Nov. 22, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ESGL Holdings Ltd (NASDAQ: ESGL), SciSparc Ltd (NASDAQ: SPRC), Safety Shot Inc (NASDAQ: SHOT), PaxMedica Inc ...
2023-11-21 10:05:00 ET DENVER, Colo., Nov. 21, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Anghami Inc (NASDAQ: ANGH), ABVC BioPharma Inc (NASDAQ: ABVC), Can Fite Biofarma Ltd (AMEX: CANF), Altamira T...
News, Short Squeeze, Breakout and More Instantly...
FREMONT, CA - ( NewMediaWire ) - July 02, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and it...
The Company holds a U.S. patent for the same treatment FREMONT, CA - ( NewMediaWire ) - June 25, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, a...
FREMONT, CA - ( NewMediaWire ) - June 12, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company receive...